Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma, Large B-Cell, Diffuse 23Burkitt Lymphoma 14Sarcoma 13Neoplasms 11Lymphoma, Follicular 11Lymphoma 10Hodgkin Disease 9Breast Neoplasms 9Triple Negative Breast Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Endometrial Neoplasms 8Ovarian Neoplasms 7Lymphoma, B-Cell 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Wilms Tumor 4Recurrence 4Osteosarcoma 4Neoplasm Metastasis 4Liposarcoma 4Fallopian Tube Neoplasms 4Sarcoma, Ewing 3Neuroblastoma 3Lymphoproliferative Disorders 3Lymphoma, T-Cell 3Lymphoma, Mantle-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Biphenotypic, Acute 3Leiomyosarcoma 3

Interventions

Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastric Cancer Peritoneal Metastases × Doxorubicin × 90 days × Clear all
NCT07517419 2026-04-08

PIPAC in Gastric Peritoneal Metastasis

Chinese University of Hong Kong

Phase 2 Enrolling by invitation
30 enrolled
Gastrointestinal

Gastric Cancer Peritoneal Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡